SERPINA1 and metabolic dysfunction-associated steatotic liver disease: Recently, Strnad et al. [13] reported that the SERPINA1 Pi*Z-allele was associated with disease severity and an increased risk of developing cirrhosis in patients with NAFLD and ALD.